Reclaiming Global Public Health
Bill Of Health
SEPTEMBER 20, 2022
New mRNA vaccines, underpinned by decades of public investment , had been authorized by global regulators. Dose shortages elevated the role of pharmaceutical executives. The answer to one of the most important public health questions of our time — who gets access to vaccines? — Private decisions did not match public health need.
98 
Let's personalize your content